Management of Elevated Ferritin Levels Due to Inflammation

Understanding Ferritin in Inflammatory States

Ferritin is an acute phase reactant that increases during inflammation, potentially masking underlying iron deficiency, according to the European Crohn’s and Colitis Organisation 1, 2
In the presence of inflammation, serum ferritin up to 100 μg/L may still be consistent with iron deficiency, making traditional cutoffs unreliable, as suggested by the American Gastroenterological Association 3, 4
Inflammation can cause functional iron deficiency where iron is sequestered and unavailable for erythropoiesis despite adequate stores, as noted by the National Kidney Foundation 5

Measure inflammatory markers (CRP, ESR, leukocyte count) alongside ferritin to determine if inflammation is present, recommended by the European Crohn’s and Colitis Organisation 1, 4
Evaluate transferrin saturation (TSAT) - a TSAT <20% has high sensitivity for diagnosing absolute or functional iron deficiency even when ferritin is elevated, according to the American Society of Hematology 6, 2
Consider the pattern of laboratory values, such as ferritin >100 μg/L with TSAT <16% suggesting anemia of chronic disease, as indicated by the American College of Gastroenterology 2, 3

The first step in managing inflammation-induced hyperferritinemia is treating the underlying inflammatory condition, as recommended by the European Crohn’s and Colitis Organisation 1, 2
When iron deficiency is confirmed or strongly suspected despite elevated ferritin, intravenous (IV) iron should be administered rather than oral iron, especially in cases of functional iron deficiency with inflammation, according to the American Society of Hematology 7, 6
For patients with inflammatory bowel disease and other chronic inflammatory conditions, IV iron formulations such as ferric derisomaltose (FDI), iron sucrose, or ferric carboxymaltose (FCM) are recommended, as suggested by the American Gastroenterological Association 7

Evaluate CBC and iron parameters (ferritin, TSAT) 4-8 weeks after iron infusion, recommended by the American Society of Hematology 7
Expect hemoglobin to increase by 1-2 g/dL within 4-8 weeks of therapy, as indicated by the American College of Gastroenterology 7
In patients with inflammation, the goal ferritin level should be adjusted upward compared to patients without inflammation, according to the American Society of Hematology 6, 4

In chronic inflammatory conditions like inflammatory bowel disease, recurrence of anemia is common (>50% after 1 year) and often indicates ongoing inflammation, as noted by the European Crohn’s and Colitis Organisation 2
Patients with chronic inflammatory conditions require more frequent monitoring of iron status, recommended by the American Society of Hematology 7, 2

Do not rely solely on ferritin levels to assess iron status in inflammatory states, as warned by the European Crohn’s and Colitis Organisation 1, 4
Avoid assuming normal iron stores based on normal or elevated ferritin when inflammation is present, cautioned by the National Kidney Foundation 5
Do not withhold iron therapy based on elevated ferritin alone if other markers suggest iron deficiency, advised by the American Society of Hematology 7, 6

The American Journal of Hematology suggests that ferritin is an acute-phase reactant that rises during inflammation independent of actual iron stores, making traditional cutoffs unreliable in inflammatory states 8

Transferrin saturation <20% has high sensitivity for diagnosing absolute or functional iron deficiency even when ferritin is elevated due to inflammation 8

The American College of Hematology recommends that in the absence of inflammation, the goal ferritin is 50 ng/mL, regardless of sex, but in patients with inflammatory conditions, the target ferritin should be adjusted upward 8
The majority of patients with CKD will require supplemental iron during ESA therapy, and ferritin synthesis is blunted during inflammation even when absolute iron deficiency is present 8

Evaluate transferrin saturation alongside ferritin—never use ferritin alone to assess iron status in inflammatory conditions, as recommended by the American Journal of Hematology 8
Elevated ferritin with low transferrin saturation (<20%) indicates functional iron deficiency or inflammatory iron block 8

IV iron formulations such as ferric derisomaltose, iron sucrose, or ferric carboxymaltose are recommended for patients with inflammatory bowel disease and other chronic inflammatory conditions, according to the American Journal of Hematology 8

Evaluate CBC and iron parameters 4-8 weeks after iron infusion, as circulating iron interferes with assays and leads to spurious results, as suggested by the American Journal of Hematology 8
Expect hemoglobin to increase by 1-2 g/dL within 4-8 weeks of therapy, as recommended by the American Journal of Hematology 8

Soluble transferrin receptor (sTfR) is elevated in iron deficiency and not affected by inflammation, though it has limitations, as noted by the American Journal of Hematology 8
Reticulocyte hemoglobin content (CHr) or equivalent (RET-He) provides direct assessment of functional iron availability, as suggested by the American Journal of Hematology 8